Paradigm Spine Tingles for $8.2M (CityBizList – New York)
NEW YORK — Medical device company Paradigm Spine, LLC raised $8.15 million of a targeted $14.60 million.
Named in the related SEC filing were Chairman Anthony G. Viscogliosi, CEO Marc R. Viscogliosi, President and COOGuntmar Eisen, CFO Steven Amelio, and Hallett Matthews, President of VB Professional Services. Directors listed include David Robbins, Trevi Health Ventures; Jeffrey C. Lightcap, HealthCor Partners; John Moran; and Arthur S. Steffee, MD, retired orthopedic surgeon and inventor.
Paradigm Spine was founded in 2004 by Viscogliosi Brothers, LLC., Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi.
Anthony G. Viscogliosi is a founder of Small Bone Innovations, Inc., where he currently serves as Chairman and Chief Executive Officer. He co-founded Viscogliosi Bros., LLC, a merchant bank and venture capital firm focused on the musculoskeletal/orthopedics industry, in 1999. Viscogliosi is also a founder of Spine Solutions, Inc., RayMedica, Inc., Ascent Healthcare Solutions, Inc.; a co-founder of Musculoskeletal Clinical & Regulatory Advisers, LLC; and a founder and Partner in 6 orthopedic focused venture capital & private equity funds, as well as an orthopedic focused hedge fund. In addition, he is a founder of the NYU-HJD Viscogliosi Bros. Spine Center.
Marc R. Viscogliosi was a research associate at Stifel, Nicolaus & Co., Inc., Rodman & Renshaw, Inc. and Commonwealth Associates. From 1992 to 1993 he worked as an intern at Martin Simpson & Co. Mr. Viscogliosi has served on two Boards of Directors of musculoskeletal companies. Mr. Viscogliosi graduated from New York University in 1999 with a BA in Economics and Political Science.
Paradigm Spine, LLC (Paradigm Spine) is a privately-held medical device company, engaged in the development of spinal implants for the spine and orthopedic markets. It develops non fusion spinal implants, motion preserving products and tissue sparing products. Its products are used for spinal stabilization, rebalances spinal segment and restores natural anatomical function.
The company earlier raised $26.3 million.